Here are four things to know. 1. Levetiracetam is intended to treat partial onset seizures related to epilepsy. 2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR. 3. Sales of ...
January 25, 2012 — The US Food and Drug Administration (FDA) has given the go-ahead for the use of levetiracetam (Keppra, UCB Pharmaceuticals) as adjunctive treatment for partial-onset seizures in ...
BRUSSELS (Reuters) - Belgian pharmaceutical group UCB said on Tuesday it was retaining its 2009 profit forecast despite generic competition for its blockbuster drug Keppra that analysts said appeared ...
Q: My 7-year-old child had not had a seizure in four years. Her epilepsy has been controlled with Keppra and the ketogenic diet. Recently, she was switched to levetiracetam, the generic form of Keppra ...
Raises revenue forecast, sees profit at top end of range 9-month revenues flat Competition to Keppra weaker than expected (Adds details) BRUSSELS, OCT 27 - Belgian drugmaker UCB raised its 2011 sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results